cystamine has been researched along with homocystamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson, E; Joseph, J; Kalyanaraman, B; Parthasarathy, S | 1 |
| BERGERET, B; BLASCHKO, H | 1 |
| Cohen, E; Garty, M; Sharabi, A; Sulkes, J | 1 |
| Gao, W; Wang, HY; Wang, YS; Zhang, P | 1 |
| Bertollo, EM; Biselli, PM; Godoy, MF; Graça, CR; Guerzoni, AR; Pavarino-Bertelli, EC; Souza, DR | 1 |
| Agam, G; Belmaker, RH; Bromberg, A; Levine, J; Nemetz, B | 1 |
| Joubert, LM; Manore, MM | 1 |
| Savill, P | 1 |
| Berenson, GS; Chen, W; Ruan, L; Srinivasan, SR; Toprak, A; Xu, J | 1 |
| Safarinejad, MR; Safarinejad, S; Shafiei, N | 1 |
| Broda, G; Iwanicka-Pronicka, K; Korniszewski, L; Lechowicz, U; Mueller-Malesinska, M; Oldak, M; Pollak, A; Płoski, R; Skarzynski, H; Skorka, A; Sobczyk-Kopciol, A; Waskiewicz, A | 1 |
1 trial(s) available for cystamine and homocystamine
| Article | Year |
|---|---|
Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route.
Topics: Administration, Oral; Administration, Sublingual; Cystamine; Humans; Middle Aged; Schilling Test; Treatment Outcome; Vitamin B 12; Vitamin B 12 Deficiency | 2003 |
10 other study(ies) available for cystamine and homocystamine
| Article | Year |
|---|---|
Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein.
Topics: Antibody Specificity; Apolipoprotein B-100; Apolipoproteins B; Binding, Competitive; Cystamine; Enzyme-Linked Immunosorbent Assay; Homocysteine; Lipoproteins, LDL; Lysine; Vascular Diseases | 1998 |
The oxidation of cystamine and homocystamine by mammalian enzymes.
Topics: Amine Oxidase (Copper-Containing); Amines; Animals; Cystamine; Guinea Pigs; Horses; Kidney; Mercaptoethylamines; Monoamine Oxidase; Oxidation-Reduction; Oxidoreductases; Sheep; Swine | 1957 |
Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.
Topics: Adult; Aged; Asian People; Case-Control Studies; China; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Cystamine; Female; Folic Acid; Folic Acid Deficiency; Humans; Hyperhomocysteinemia; Male; Middle Aged; Radioimmunoassay; Retinal Vein Occlusion; Risk Factors | 2006 |
Methylenetetrahydrofolate reductase gene polymorphism and its association with coronary artery disease.
Topics: Alleles; Brazil; Cineangiography; Coronary Artery Disease; Cystamine; Epidemiologic Methods; Female; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Smoking | 2007 |
No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Case-Control Studies; Cohort Studies; Cystamine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Leukocytes; Male; Middle Aged; Schizophrenia; Sex Factors | 2008 |
The role of physical activity level and B-vitamin status on blood homocysteine levels.
Topics: Adult; Anthropometry; Cross-Sectional Studies; Cystamine; Diet; Exercise; Female; Humans; Male; Oxygen Consumption; Surveys and Questionnaires; Vitamin B Complex; Young Adult | 2008 |
Calculating CVD risk in older patients.
Topics: Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cystamine; Humans; Risk Assessment | 2009 |
Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study.
Topics: Adult; Black or African American; Cohort Studies; Cystamine; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Multivariate Analysis; Odds Ratio; United States; White People; Young Adult | 2009 |
Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Topics: Adult; Aged; Case-Control Studies; Cystamine; DNA; Folic Acid; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin B 12 | 2010 |
MTHFR 677T is a strong determinant of the degree of hearing loss among Polish males with postlingual sensorineural hearing impairment.
Topics: Adult; Aged; Auditory Threshold; Case-Control Studies; Cystamine; Female; Genotype; Hearing Loss, Sensorineural; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Poland; Polymorphism, Single Nucleotide; White People; Young Adult | 2012 |